Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis
- PMID: 16025478
- PMCID: PMC6807766
- DOI: 10.1002/jcla.20073
Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis
Abstract
Increased activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) can be used as an early indicator of damage to the tubular epithelium. Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease. Nephritis is known as the most serious complication of SLE and the strongest predictor of poor outcome. In this study urinary NAG excretion was investigated in 24 SLE patients with normal renal function (serum creatinine < or =1.2 mg/dL) and the results were compared with those from 26 untreated patients with rheumatoid arthritis (RA) and 27 healthy controls. The SLE patients were divided into two groups according to their urinary total protein levels: group A consisted of 16 patients with < or =3.5 g/day proteinuria, and group B consisted of eight patients with nephrotic-range proteinuria (>3.5 g/day). Serum and urinary creatinine, total urinary protein levels, and urinary NAG excretion were measured in patients with SLE and RA. In addition, serum C3 and C4 levels were determined in the SLE patients. Renal biopsies were performed in all of the SLE patients. Glomerular lesions were classified according to WHO criteria for lupus nephritis (LN) I-V. The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was used to assess disease activity. Urinary NAG excretion was significantly higher in the SLE groups than in the healthy controls (P<0.001). In urinary NAG excretion there was also significant difference between SLE groups and RA patients (P<0.001). However, there was no significant difference in NAG excretion between the RA and control groups (P=0.062). Urinary NAG excretion was significantly higher (P<0.05) in group B compared to group A. There were no differences in SLEDAI scores, ages, and serum creatinine levels between study groups (P=0.601, P=0.285, P=0.669, respectively). Elevated SLEDAI values and hypocomplementemia were detected more often in younger patients (P<0.010, r=-0.529 and P<0.010, r=-0.569, respectively). There was a strong positive correlation between proteinuria and urinary NAG activity (P<0.001, r=0.759). These results suggest that the determination of urinary NAG activity may be a useful supplement to the routine biochemical analysis performed on the urine in cases of SLE.
Similar articles
-
The dynamics of urinary N-acetyl-β-D-glucosaminidase (NAG), a marker of renal tubular dysfunction, in patients with lupus nephritis undergoing oral prednisone therapy.Immunopharmacol Immunotoxicol. 2012 Feb;34(1):163-9. doi: 10.3109/08923973.2011.585343. Epub 2011 Jun 9. Immunopharmacol Immunotoxicol. 2012. PMID: 21651460
-
Increased excretions of glycosaminoglycans and heparan sulfate in lupus nephritis and rheumatoid arthritis.Rheumatol Int. 2003 Sep;23(5):221-5. doi: 10.1007/s00296-003-0294-3. Epub 2003 Mar 12. Rheumatol Int. 2003. PMID: 14504913
-
Urinary N-acetyl-beta-D-glucosaminidase in rheumatoid arthritis.Exp Mol Med. 1998 Sep 30;30(3):165-9. doi: 10.1038/emm.1998.24. Exp Mol Med. 1998. PMID: 9873839
-
Commentary on the Current Guidelines for the Diagnosis of Lupus Nephritis Flare.Curr Rheumatol Rep. 2019 Feb 27;21(4):12. doi: 10.1007/s11926-019-0809-x. Curr Rheumatol Rep. 2019. PMID: 30810824 Review.
-
Urinary N-acetyl-beta-d-glucosaminidase levels in diabetic adults.J Lab Physicians. 2019 Jan-Mar;11(1):1-4. doi: 10.4103/JLP.JLP_164_17. J Lab Physicians. 2019. PMID: 30983794 Free PMC article. Review.
Cited by
-
Urinary N-acetyl-D-glucosaminidase can predict bleeding after a percutaneous kidney biopsy.BMC Nephrol. 2024 Jul 22;25(1):234. doi: 10.1186/s12882-024-03658-z. BMC Nephrol. 2024. PMID: 39039446 Free PMC article.
-
Urinary N-acetyl-β-d-glucosaminidase-creatine ratio is a valuable predictor for advanced diabetic kidney disease.J Clin Lab Anal. 2023 Jan;37(1):e24769. doi: 10.1002/jcla.24769. Epub 2022 Dec 26. J Clin Lab Anal. 2023. PMID: 36572996 Free PMC article.
-
Urine biomarkers in juvenile-onset SLE nephritis.Pediatr Nephrol. 2013 Mar;28(3):363-74. doi: 10.1007/s00467-012-2184-y. Epub 2012 May 16. Pediatr Nephrol. 2013. PMID: 22588674 Review.
-
Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems.Open Access Rheumatol. 2016 Sep 19;8:81-91. doi: 10.2147/OARRR.S112829. eCollection 2016. Open Access Rheumatol. 2016. PMID: 27843374 Free PMC article. Review.
-
Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis.Biomolecules. 2023 Oct 31;13(11):1601. doi: 10.3390/biom13111601. Biomolecules. 2023. PMID: 38002282 Free PMC article. Review.
References
-
- Price RG. The role of NAG (N‐acetyl‐β‐D‐glucosaminidase) in the diagnosis of kidney disease, including the monitoring of nephrotoxicity. Clin Nephrol 1992;38:14–19. - PubMed
-
- Grande JP. Mechanisms of progression of renal damage in lupus nephritis: pathogenesis of renal scarring. Lupus 1998;7:604–610. - PubMed
-
- Ponticelli C, Moroni G. Flares in lupus nephritis: incidence, impact on renal survival and management. Lupus 1998;7:635–638. - PubMed
-
- Myllykangas‐Luosujärvi RA, Aho K, Isomäki Ha. Mortality in rheumatoid arthritis. Semin Arthritis Rheum 1995;25:193–202. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous